Tüm alıştırma soruları

8270 soru

Soru 4521Soru →

A 3232-year-old man comes to the clinic to establish care after recently testing positive for human immunodeficiency virus (HIV). He is currently asymptomatic and has no history of opportunistic infections. Vital signs are within normal limits. Physical examination reveals no lymphadenopathy, oral thrush, or skin lesions. Laboratory evaluation shows a CD4 T-lymphocyte count of 38/μL38/\mu\text{L} and an HIV RNA viral load of 280,000280,000 copies/mL. Serologic testing is positive for *Toxoplasma gondii* IgG antibodies. An interferon-gamma release assay is negative. An antiretroviral therapy (ART) regimen consisting of bictegravir, emtricitabine, and tenofovir alafenamide is initiated today. In addition to ART, which of the following is the most appropriate prophylactic antimicrobial regimen for this patient?

Cevabı ve açıklamayı göster

Cevap: Trimethoprim-sulfamethoxazole only

Cevap

Trimethoprim-sulfamethoxazole only
The correct answer provides targeted prophylaxis for the exact pathogens this patient is at risk for without inappropriately prescribing unneeded antimicrobials. A CD4 count <200/μL< 200/\mu\text{L} necessitates prophylaxis against *Pneumocystis jirovecii* pneumonia, and a count <100/μL< 100/\mu\text{L} combined with positive IgG antibodies requires prophylaxis against *Toxoplasma gondii*. Trimethoprim-sulfamethoxazole provides highly effective coverage for both. Although the CD4 count is <50/μL< 50/\mu\text{L}, primary prophylaxis for *Mycobacterium avium* complex (MAC) is no longer recommended for patients who are immediately starting antiretroviral therapy.

Adım Adım Çözüm

1
Analyze the patient's CD4 count and serologic status.
The CD4 count is 38/μL38/\mu\text{L} (which is <200/μL< 200/\mu\text{L} and <100/μL< 100/\mu\text{L}) and Toxoplasma IgG is positive.
To identify which opportunistic pathogens the patient is currently at high risk for acquiring.
2
Identify the required primary prophylaxis regimens.
Prophylaxis is urgently required for Pneumocystis jirovecii (CD4 <200/μL< 200/\mu\text{L}) and Toxoplasma gondii (CD4 <100/μL< 100/\mu\text{L} with positive IgG). Trimethoprim-sulfamethoxazole effectively covers both.
To select the appropriate evidence-based antimicrobial agent.
3
Determine if Mycobacterium avium complex (MAC) prophylaxis is needed.
MAC prophylaxis (such as azithromycin) is not indicated because the patient is initiating fully suppressive antiretroviral therapy (ART) today.
Contemporary guidelines have removed the recommendation for MAC prophylaxis in patients starting ART, even when the CD4 count is <50/μL< 50/\mu\text{L}.

Anahtar Kavram

In patients with HIV, primary prophylaxis for Mycobacterium avium complex (MAC) is no longer recommended if antiretroviral therapy is initiated immediately, but prophylaxis for Pneumocystis jirovecii and Toxoplasma gondii is still required based on CD4 thresholds.
Soru 4522Soru →

Five days after undergoing an elective right hemicolectomy with primary anastomosis for colon adenocarcinoma, a 6565-year-old patient suddenly experiences severe, worsening abdominal pain and bilious vomiting. Over the past 1212 hours, his condition has significantly deteriorated. He has not had any bowel movements or passed flatus since the surgery. His temperature is now 39.1∘C39.1^\circ\text{C} (102.4∘F102.4^\circ\text{F}), blood pressure has dropped to 90/55 mmHg90/55\text{ mmHg}, pulse is 122/min122/\text{min}, and respirations are 24/min24/\text{min}. The patient appears diaphoretic and is lying completely still in bed. Physical examination reveals a markedly distended abdomen that is diffusely tender to palpation, with prominent guarding and rebound tenderness in all four quadrants. Auscultation reveals absent bowel sounds. The surgical incision site appears clean, dry, and intact. Laboratory tests demonstrate a leukocyte count of 21,000/mm321,000/\text{mm}^3 with 15%15\% band forms and a serum lactate concentration of 4.2 mmol/L4.2\text{ mmol/L}. Which of the following are the most appropriate next steps in the management of this patient? (Select 2)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Immediate return to the operating room for surgical re-exploration; Initiation of empiric intravenous antimicrobial therapy

Cevap

The correct next steps are immediate return to the operating room for surgical re-exploration and initiation of empiric intravenous antimicrobial therapy.
This patient presents with a classic picture of an anastomotic leak, which most frequently occurs between postoperative days 5 and 7 following intestinal surgery. The spillage of enteric contents into the peritoneal cavity causes secondary peritonitis, presenting as severe, diffuse abdominal pain with guarding and rebound tenderness. The patient is also exhibiting signs of systemic inflammatory response and progression to septic shock, indicated by high fever, tachycardia, hypotension, leukocytosis with a left shift, and elevated serum lactate. The fundamental management of septic shock in the setting of an acute surgical abdomen involves aggressive hemodynamic support, immediate administration of broad-spectrum intravenous antibiotics covering enteric flora, and urgent surgical re-exploration to achieve source control (e.g., washout and proximal diversion). Delaying surgery in this scenario significantly increases mortality.

Adım Adım Çözüm

1
Analyze the patient's postoperative timeline and clinical presentation.
The patient is on postoperative day 5 and presents with fever, tachycardia, hypotension, and diffuse peritonitis (guarding, rebound tenderness).
Identifying the timing and severity of symptoms helps narrow the differential diagnosis for postoperative fever and abdominal pain.
2
Identify the underlying pathology.
The presentation strongly suggests an anastomotic leak leading to secondary peritonitis and septic shock.
Anastomotic leaks typically present between postoperative days 5 and 7. The spillage of enteric contents causes severe peritonitis and rapid hemodynamic collapse.
3
Determine the required management sequence for intra-abdominal sepsis.
The patient requires immediate source control and systemic treatment of infection.
In septic shock secondary to an acute surgical abdomen, broad-spectrum intravenous antibiotics must be administered promptly alongside aggressive fluid resuscitation, followed immediately by surgical re-exploration to control the source of contamination.

Anahtar Kavram

Patients presenting with signs of generalized peritonitis and septic shock following bowel anastomosis require immediate broad-spectrum antibiotics and emergent surgical re-exploration for source control.
Soru 4523Soru →

Match each pediatric patient presentation with the most appropriate immunization recommendation or contraindication based on their specific health status.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 2-year-old child with sickle cell disease who has completed the routine infant pneumococcal conjugate vaccine series
An 11-year-old child with a newly diagnosed terminal complement component (C5-C9) deficiency
A 6-year-old child currently receiving induction chemotherapy for acute lymphoblastic leukemia
A 16-year-old pregnant adolescent currently at 28 weeks of gestation

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The 2-year-old with sickle cell disease matches with PPSV23 administration; the 11-year-old with complement deficiency matches with MenB vaccine administration; the 6-year-old on chemotherapy matches with the absolute contraindication to the MMR vaccine; and the 16-year-old at 28 weeks gestation matches with Tdap vaccine administration.
Each patient presentation corresponds to a unique deviation or addition to the routine immunization schedule. Sickle cell patients require PPSV23 at age 2 due to functional asplenia. Complement deficiency requires MenB vaccination. Chemotherapy mandates the avoidance of live vaccines like MMR. Pregnancy requires Tdap between 27-36 weeks regardless of prior vaccination history.

Adım Adım Çözüm

1
Evaluate the 2-year-old with sickle cell disease.
Matches with administration of PPSV23.
Functional asplenia requires expanded protection against Streptococcus pneumoniae; PPSV23 is given at age 2 years following the infant conjugate series.
2
Evaluate the 11-year-old with terminal complement deficiency.
Matches with administration of MenB vaccine.
Complement deficiency causes high risk for meningococcal disease. MenB is indicated for these high-risk patients starting at 10 years of age.
3
Evaluate the 6-year-old receiving chemotherapy.
Matches with absolute contraindication to the MMR vaccine.
Chemotherapy induces severe immunosuppression, making live-attenuated vaccines dangerous.
4
Evaluate the 16-year-old pregnant adolescent at 28 weeks gestation.
Matches with administration of Tdap vaccine.
Tdap is routinely indicated in all pregnancies between 27 and 36 weeks to protect the newborn from pertussis.

Anahtar Kavram

Immunization indications and contraindications for special pediatric populations (asplenia, complement deficiency, immunosuppression, and pregnancy).
Soru 4524Soru →

A 50-year-old male presents to the outpatient clinic reporting progressive weakness and a metallic taste in his mouth over the last several weeks. He has a 15-year history of poorly controlled hypertension. His blood pressure is 165/95 mm Hg165/95 \text{ mm Hg}, pulse is 84/min84/\text{min}, and respiratory rate is 22/min22/\text{min}. Physical examination reveals trace bilateral lower extremity edema and a pale complexion. Laboratory studies are obtained and reveal the following:

Serum chemistry:
Na+Na^+: 140 mEq/L140 \text{ mEq/L}
K+K^+: 5.2 mEq/L5.2 \text{ mEq/L}
Cl−Cl^-: 102 mEq/L102 \text{ mEq/L}
HCO3−HCO_3^-: 12 mEq/L12 \text{ mEq/L}
Blood urea nitrogen: 85 mg/dL85 \text{ mg/dL}
Serum creatinine: 5.5 mg/dL5.5 \text{ mg/dL}

Arterial blood gas (room air):
pH: 7.257.25
pCO2pCO_2: 26 mm Hg26 \text{ mm Hg}
pO2pO_2: 95 mm Hg95 \text{ mm Hg}

Based on these findings, which of the following best describes this patient's current acid-base status?

Cevabı ve açıklamayı göster

Cevap: High anion gap metabolic acidosis with appropriate respiratory compensation

Cevap

High anion gap metabolic acidosis with appropriate respiratory compensation
This patient has a high anion gap metabolic acidosis secondary to advanced chronic kidney disease (uremia). The diagnosis requires a systematic approach to the arterial blood gas and serum chemistry. The patient is acidemic (pH=7.25pH = 7.25). The primary driver of the acidemia is the low bicarbonate (12 mEq/L12 \text{ mEq/L}), confirming a metabolic acidosis. Next, the anion gap is calculated as Na+−(Cl−+HCO3−)=140−(102+12)=26 mEq/LNa^+ - (Cl^- + HCO_3^-) = 140 - (102 + 12) = 26 \text{ mEq/L}. Because this is significantly higher than the normal range (8−12 mEq/L8-12 \text{ mEq/L}), it is a high anion gap metabolic acidosis. Finally, Winter's formula (1.5×HCO3−+8±21.5 \times HCO_3^- + 8 \pm 2) is used to assess for a mixed disorder. The expected pCO2pCO_2 is (1.5×12)+8=26±2 mm Hg(1.5 \times 12) + 8 = 26 \pm 2 \text{ mm Hg} (range 24−28 mm Hg24-28 \text{ mm Hg}). Since the patient's measured pCO2pCO_2 (26 mm Hg26 \text{ mm Hg}) matches the expected value perfectly, this is a simple, fully compensated high anion gap metabolic acidosis.

Adım Adım Çözüm

1
Determine the primary acid-base disturbance by evaluating the pH, pCO2, and bicarbonate.
The pH is 7.257.25 (acidemia), pCO2pCO_2 is 26 mm Hg26 \text{ mm Hg} (low), and HCO3−HCO_3^- is 12 mEq/L12 \text{ mEq/L} (low).
An acidic pH paired with a low bicarbonate identifies the primary process as a metabolic acidosis.
2
Calculate the serum anion gap using the formula: AG=Na+−(Cl−+HCO3−)AG = Na^+ - (Cl^- + HCO_3^-).
AG=140−(102+12)=26 mEq/LAG = 140 - (102 + 12) = 26 \text{ mEq/L}.
Differentiating between a normal anion gap (8−12 mEq/L8-12 \text{ mEq/L}) and a high anion gap guides the differential diagnosis. An AG of 26 mEq/L26 \text{ mEq/L} confirms a high anion gap metabolic acidosis, likely secondary to uremia given the elevated BUN and creatinine.
3
Apply Winter's formula to determine the expected respiratory compensation: Expected pCO2=(1.5×HCO3−)+8±2Expected\ pCO_2 = (1.5 \times HCO_3^-) + 8 \pm 2.
Expected pCO2=(1.5×12)+8±2=18+8±2=26±2 mm HgExpected\ pCO_2 = (1.5 \times 12) + 8 \pm 2 = 18 + 8 \pm 2 = 26 \pm 2 \text{ mm Hg} (range 24−28 mm Hg24-28 \text{ mm Hg}).
Calculating expected pCO2pCO_2 is necessary to identify if a secondary, superimposed respiratory disorder is present.
4
Compare the measured pCO2pCO_2 with the calculated expected pCO2pCO_2 range.
The measured pCO2pCO_2 is 26 mm Hg26 \text{ mm Hg}, which is exactly equal to the calculated expected value.
Because the measured value falls perfectly within the expected range, there is appropriate respiratory compensation without a superimposed respiratory disorder.

Anahtar Kavram

Evaluation of metabolic acidosis requires a step-wise approach: first calculating the anion gap, followed by calculating the expected respiratory compensation using Winter's formula (Expected pCO2=1.5×HCO3−+8±2Expected\ pCO_2 = 1.5 \times HCO_3^- + 8 \pm 2).
Tahmini Süre:1m 0s
Soru 4525Soru →

A 4-year-old girl is brought to the pediatric clinic for a well-child examination before starting preschool. She has a medical history of end-stage renal disease secondary to severe reflux nephropathy and underwent a deceased-donor kidney transplantation one year ago. Her daily medication regimen includes tacrolimus, mycophenolate mofetil, and low-dose prednisone. During the interview, the mother expresses concern that her daughter might have a developmental delay because she cannot yet skip across the room or tie her own shoelaces. On examination, the girl hops confidently on one foot, clearly copies a cross on a piece of paper, and speaks in fully intelligible sentences. The mother notes she engages frequently in cooperative play with her older brother. Physical examination is unremarkable, with well-healed surgical scars and normal vital signs. A review of her state immunization registry indicates she received all routine childhood vaccinations up to 24 months of age. The mother asks which vaccines her daughter should receive today and if a developmental referral is warranted. Which of the following is the most appropriate management for this patient?

Cevabı ve açıklamayı göster

Cevap: Give diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines, and validate that her current skills are age-appropriate

Cevap

Give diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines, and validate that her current skills are age-appropriate.
This 4-year-old patient is on a regimen of tacrolimus, mycophenolate mofetil, and prednisone following a kidney transplant, placing her in a state of severe cellular immunosuppression. In such patients, live-attenuated vaccines (e.g., measles-mumps-rubella [MMR], varicella, intranasal influenza) are strictly contraindicated due to the high risk of uncontrolled vaccine-strain viral replication and disseminated disease. However, inactivated vaccines (e.g., diphtheria-tetanus-acellular pertussis [DTaP], inactivated poliovirus [IPV], intramuscular influenza) are safe, do not cause infectious disease, and should be administered according to the routine schedule to provide necessary protection, even if the resulting immune response may be blunted compared to healthy children. Regarding her neurodevelopment, she has successfully met the milestones expected for a 4-year-old, which include hopping on one foot, copying a cross, cooperative play, and 100% speech intelligibility. Her inability to skip or tie shoelaces is entirely normal, as these specific gross and fine motor skills are typically mastered by age 5. Therefore, she requires only age-appropriate inactivated vaccines and parental reassurance.

Adım Adım Çözüm

1
Evaluate the patient's developmental milestones to determine if a delay is present.
The patient can hop on one foot, copy a cross, and engage in cooperative play, which perfectly align with 4-year-old milestones. Skipping and tying shoelaces are 5-year-old milestones.
Accurately identifying normal development is necessary to decide between parental reassurance and formal developmental referral.
2
Assess the patient's immunization needs and immune status.
The patient is due for her 4-6 year pre-kindergarten booster vaccines (DTaP, IPV, MMR, Varicella). However, she is on a potent immunosuppressive regimen (tacrolimus, mycophenolate, prednisone) for a kidney transplant.
Vaccine safety profiles differ based on host immune competence.
3
Formulate the most appropriate management plan based on the assessments.
Administer the inactivated vaccines (DTaP, IPV) safely, strictly withhold the live-attenuated vaccines (MMR, Varicella), and provide reassurance that her development is completely on track.
Live vaccines carry a risk of disseminated vaccine-strain infection in immunocompromised patients, but inactivated vaccines do not and remain highly recommended.

Anahtar Kavram

Immunization guidelines in immunocompromised pediatric patients and normal 4-year-old developmental milestones.
Soru 4526Soru →

An executive health screening is performed for a 45-year-old man who reports a 6-month history of significant fatigue, reduced libido, and a constant feeling of coldness. Physical examination shows a heart rate of 56/min56/min, normal blood pressure, and delayed relaxation of the deep tendon reflexes. Laboratory evaluation reveals:

Thyroid-stimulating hormone (TSH): 1.1μU/mL1.1 \mu U/mL (Normal: 0.4−4.0μU/mL0.4 - 4.0 \mu U/mL)
Free thyroxine (T4): 0.4ng/dL0.4 ng/dL (Normal: 0.9−1.7ng/dL0.9 - 1.7 ng/dL)

Which of the following additional findings is most likely to be present in this patient?

Cevabı ve açıklamayı göster

Cevap: Decreased serum adrenocorticotropic hormone concentration

Cevap

Decreased serum adrenocorticotropic hormone concentration
The patient's laboratory results (low free T4 with an inappropriately normal TSH) are diagnostic of central hypothyroidism, which is caused by a failure of the pituitary gland or hypothalamus to produce sufficient TSH. This is frequently due to a mass lesion such as a pituitary adenoma. When the anterior pituitary gland is compromised, other hormones are also frequently deficient (panhypopituitarism). Therefore, a decreased serum adrenocorticotropic hormone (ACTH) concentration, as well as decreased gonadotropins (LH, FSH) causing his reduced libido, would most likely be present.

Adım Adım Çözüm

1
Interpret the thyroid function tests.
The patient has a low free T4 level, indicating hypothyroidism, but the TSH level is within the normal reference range.
To establish the primary hormonal abnormality.
2
Determine the etiology of the hypothyroidism based on the TSH response.
A low free T4 with an inappropriately normal (or low) TSH points to central (secondary) hypothyroidism, typically due to pituitary or hypothalamic dysfunction.
Primary hypothyroidism would present with an elevated TSH due to a lack of negative feedback on the intact pituitary gland.
3
Identify associated findings of pituitary dysfunction.
Patients with central hypothyroidism often have panhypopituitarism, which involves deficiencies in other anterior pituitary hormones, including adrenocorticotropic hormone (ACTH) and gonadotropins.
To predict what other clinical or laboratory abnormalities the patient might have.

Anahtar Kavram

Diagnosis of central hypothyroidism and recognition of associated panhypopituitarism
Tahmini Süre:1m 0s
Soru 4527Soru →

A 58-year-old woman is brought to the emergency department due to a 1-day history of fever, chills, and progressive shortness of breath. She completed her second cycle of systemic chemotherapy (docetaxel and cyclophosphamide) for node-positive breast cancer 8 days ago. Medical history is significant for ischemic cardiomyopathy (left ventricular ejection fraction 40%) and moderate chronic obstructive pulmonary disease. Her temperature is 38.9°C (102.0°F), blood pressure is 84/54 mm Hg, pulse is 118/min, and respirations are 24/min. Pulse oximetry shows 91% on room air. The patient appears lethargic. Jugular venous pressure is 6 cm H2O. Lung auscultation reveals crackles in the right lower lung base. Heart sounds are rapid but regular, with no S3 gallop. The extremities are warm to the touch. Laboratory results are as follows:

Hemoglobin: 9.8 g/dL
Leukocyte count: 600/μL600/\mu L
Absolute neutrophil count: 120/μL120/\mu L
Platelet count: 110,000/μL110,000/\mu L
Creatinine: 1.4 mg/dL
Thyroid-stimulating hormone (TSH): 0.4 μU/mL0.4\ \mu U/mL
Free T4: 0.9 ng/dL0.9\ ng/dL

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Obtain blood cultures and administer intravenous cefepime

Cevap

Obtain blood cultures and administer intravenous cefepime
The correct action is to obtain blood cultures and administer intravenous cefepime. This patient has febrile neutropenia (defined as a temperature > 38.3°C and an absolute neutrophil count < 500/μL), which is a life-threatening oncologic emergency. Her hypotension (84/54 mm Hg) and warm extremities strongly suggest distributive shock secondary to sepsis, likely from a pulmonary source given the right lower lobe crackles. In high-risk patients (e.g., those with hemodynamic instability or profound neutropenia), blood cultures must be drawn and empiric intravenous broad-spectrum antibiotics with anti-pseudomonal activity (such as cefepime, meropenem, or piperacillin-tazobactam) must be initiated immediately to prevent rapid clinical deterioration and death.

Adım Adım Çözüm

1
Calculate Absolute Neutrophil Count (ANC) and evaluate vital signs.
ANC is 120/μL (< 500/μL) and patient is hypotensive with fever.
Identifies the clinical syndrome as high-risk febrile neutropenia with septic shock.
2
Differentiate the etiology of shock based on physical exam findings.
Warm extremities, normal JVP, and lack of an S3 gallop indicate distributive (septic) shock rather than cardiogenic shock.
Prevents inappropriate administration of diuretics which would worsen hypotension.
3
Determine the required initial therapeutic intervention.
Immediate blood cultures followed by an anti-pseudomonal beta-lactam (cefepime).
Febrile neutropenia is an oncologic emergency requiring emergent empiric broad-spectrum antibiotic therapy.

Anahtar Kavram

High-risk febrile neutropenia presenting with septic shock requires immediate empiric broad-spectrum intravenous antibiotics with anti-pseudomonal coverage.
Soru 4528Soru →

For each clinical presentation described below, select the most appropriate initial antimicrobial agent according to current guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Erythema migrans rash following a tick bite in an endemic region
Painful, grouped vesicles on an erythematous base in a unilateral dermatomal distribution
Exudative pharyngitis, fever, and anterior cervical lymphadenopathy with a positive rapid streptococcal antigen test
Purulent urethral discharge with a nucleic acid amplification test positive for Neisseria gonorrhoeae

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The presentations correspond to Lyme disease (Doxycycline), Herpes zoster (Valacyclovir), Group A Streptococcal pharyngitis (Penicillin V), and Gonococcal urethritis (Ceftriaxone).
Each match correctly pairs a classic infectious disease syndrome with its universally accepted standard-of-care antimicrobial therapy.

Adım Adım Çözüm

1
Identify the primary diagnosis for each specific clinical presentation.
The diagnoses are early localized Lyme disease, herpes zoster, streptococcal pharyngitis, and gonorrhea.
Accurate clinical and laboratory diagnosis is required to select the appropriate pathogen-directed therapy.
2
Determine the guideline-recommended first-line antimicrobial for each established diagnosis.
Lyme disease requires doxycycline; herpes zoster requires valacyclovir; streptococcal pharyngitis requires penicillin V; gonorrhea requires ceftriaxone.
First-line agents maximize clinical efficacy while minimizing antimicrobial resistance and side effects.

Anahtar Kavram

First-line antimicrobial therapy for common outpatient infectious diseases
Soru 4529Soru →

A 42-year-old woman is diagnosed with severe, seropositive rheumatoid arthritis characterized by symmetric polyarthritis involving the metacarpophalangeal joints, morning stiffness lasting 2 hours, and bone erosions on radiography. She is preparing to begin long-term pharmacotherapy. Arrange the following clinical steps in the correct chronological sequence according to current consensus guidelines for the escalating management of rheumatoid arthritis.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: initiate methotrexate, evaluate the clinical response at 3 months, perform an interferon-gamma release assay, prescribe a TNF inhibitor, and finally switch to an alternative mechanism biologic if the TNF inhibitor fails.
Rheumatoid arthritis management follows a strict algorithmic escalation. Methotrexate is the universal first step. Because csDMARDs require time to work, a 3-month evaluation is necessary before deciding on failure. If the disease remains active, biologic escalation is warranted. However, the initiation of any biologic (especially TNF inhibitors) requires immediate prior screening for latent tuberculosis and hepatitis B/C to prevent fatal reactivation. Once cleared, the TNF inhibitor is added. Finally, if the patient fails the TNF inhibitor trial, standard practice is to switch to a biologic with a different mechanism of action rather than cycling through another TNF inhibitor.

Adım Adım Çözüm

1
Identify the standard first-line pharmacotherapy for a new diagnosis of severe rheumatoid arthritis.
The first step is initiating methotrexate alongside folic acid supplementation.
Methotrexate is the most effective initial csDMARD, serves as the anchor drug for rheumatoid arthritis, and reduces the risk of anti-drug antibodies if biologics are used later.
2
Determine the appropriate timeframe for evaluating the initial therapy.
The second step is evaluating the patient at a 3-month follow-up.
Conventional DMARDs take several months to reach full efficacy; premature escalation before an adequate trial should be avoided.
3
Recognize the required safety prerequisites before escalating to biologic therapy.
The third step is performing an interferon-gamma release assay (IGRA).
Biologics strongly increase the risk of tuberculosis reactivation, making infectious screening a mandatory chronological gatekeeper before their initiation.
4
Select the appropriate next line of therapy following csDMARD failure.
The fourth step is prescribing a TNF inhibitor as an add-on therapy.
Adding a biologic DMARD to background methotrexate is the standard of care for methotrexate non-responders.
5
Determine the management strategy if the initial biologic fails.
The final step is switching to an alternative mechanism biologic.
Patients who do not respond to a TNF inhibitor are typically transitioned to a biologic with a different mechanism of action, such as an IL-6 inhibitor or CD20 monoclonal antibody.

Anahtar Kavram

The stepwise escalation of pharmacotherapy in rheumatoid arthritis emphasizes initial csDMARD use, mandatory infectious screening immediately prior to biologic therapy, and class-switching upon primary biologic failure.
Tahmini Süre:1m 30s
Soru 4530Soru →

A 3434-year-old woman is evaluated in the emergency department for a 22-day history of heavy gingival bleeding, recurrent epistaxis, and a large bruise on her thigh after minor trauma. Her temperature is 37.9∘C37.9^\circ\text{C} (100.2∘F100.2^\circ\text{F}), pulse is 112/min112/\text{min}, and blood pressure is 105/65 mm Hg105/65 \text{ mm Hg}. Physical examination reveals pallor, diffuse petechiae over the chest and extremities, and continuous oozing of blood from the intravenous line insertion site. Laboratory studies show:

TestValueNormal Range
Hemoglobin7.8 g/dL7.8 \text{ g/dL}12.0−15.5 g/dL12.0-15.5 \text{ g/dL}
Platelet count18,000/mm318,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
Leukocyte count32,000/mm332,000/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Prothrombin time21 sec21 \text{ sec}11−15 sec11-15 \text{ sec}
aPTT45 sec45 \text{ sec}25−40 sec25-40 \text{ sec}
Fibrinogen80 mg/dL80 \text{ mg/dL}200−400 mg/dL200-400 \text{ mg/dL}

A peripheral blood smear demonstrates numerous atypical mononuclear cells with folded nuclei, heavily granulated cytoplasm, and bundles of rod-shaped cytoplasmic inclusions.

Arrange the following management steps in the most appropriate chronological sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Administer all-trans retinoic acid (ATRA) -> Perform bone marrow aspiration and biopsy -> Obtain molecular confirmation of the PML-RARA fusion -> Initiate definitive induction therapy with arsenic trioxide.
The presentation of pancytopenia, severe coagulopathy (prolonged PT/aPTT, low fibrinogen), and a peripheral smear showing atypical cells with prominent bundles of Auer rods (faggot cells) is the classic manifestation of Acute Promyelocytic Leukemia (APL) complicated by disseminated intravascular coagulation (DIC). Because this coagulopathy can rapidly lead to fatal hemorrhage, the absolute first step in management is the immediate administration of all-trans retinoic acid (ATRA). This decision must be based purely on clinical and morphologic suspicion. ATRA forces the differentiation of leukemic promyelocytes into mature neutrophils, rapidly improving the coagulopathy. Once ATRA is administered and the patient's bleeding diathesis is acutely managed (often with cryoprecipitate, fresh frozen plasma, and platelets), a bone marrow aspiration and biopsy should be performed to secure the diagnostic material. The samples obtained are then sent for cytogenetic or molecular testing to confirm the presence of the t(15;17)\text{t}(15;17) translocation, which creates the PML-RARA fusion protein. Finally, once the diagnosis is definitively confirmed, combination induction therapy (often incorporating arsenic trioxide and/or an anthracycline alongside ATRA) is initiated to achieve complete remission.

Adım Adım Çözüm

1
Analyze the clinical presentation and laboratory findings.
The patient has pancytopenia, clinical signs of disseminated intravascular coagulation (DIC), and atypical cells with bundles of Auer rods (faggot cells).
These findings are highly specific for Acute Promyelocytic Leukemia (APL), a medical emergency driven by the PML-RARA fusion protein.
2
Determine the most urgent, life-saving intervention.
Administration of all-trans retinoic acid (ATRA) is the immediate priority.
APL causes severe DIC leading to a high rate of early hemorrhagic death. ATRA induces differentiation of leukemic promyelocytes, rapidly resolving the coagulopathy, and must not be delayed.
3
Sequence the diagnostic and definitive treatment steps following initial stabilization.
Bone marrow biopsy is followed by molecular testing, which is then followed by targeted combination therapy.
Tissue acquisition must precede molecular confirmation. Once the specific genetic lesion is confirmed, final chemotherapeutic adjustments (such as adding arsenic trioxide) are made.

Anahtar Kavram

In patients with suspected Acute Promyelocytic Leukemia (APL) presenting with severe coagulopathy, all-trans retinoic acid (ATRA) must be administered immediately based on clinical suspicion, prior to bone marrow biopsy and molecular confirmation, to prevent fatal hemorrhage.
Tahmini Süre:1m 30s
Soru 4531Soru →

Match each clinical presentation with the most likely corresponding serum and urine laboratory findings.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 32-year-old woman with Sjögren syndrome presenting with proximal muscle weakness and recurrent calcium phosphate nephrolithiasis.
A 58-year-old man with long-standing diabetic nephropathy and an estimated GFR of 35 mL/min/1.73 m² on routine follow-up.
A 45-year-old man with a history of recurrent peptic ulcer disease presenting with 3 days of intractable, non-bilious emesis.
A 65-year-old man with a heavy smoking history presenting with hemoptysis and a newly diagnosed central lung mass.
A 28-year-old man with bipolar disorder on long-term mood stabilizer therapy presenting with frequent voiding and severe thirst.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches correlate specific clinical syndromes with their pathognomonic acid-base and electrolyte derangements: Sjögren syndrome with Type 1 RTA, diabetic nephropathy with Type 4 RTA, vomiting with volume-responsive metabolic alkalosis, small cell lung cancer with SIADH, and lithium use with nephrogenic diabetes insipidus.
Each clinical vignette provides classic epidemiological and historical clues that point to a specific pathophysiology, which then dictates the expected serum and urine biochemical findings.

Adım Adım Çözüm

1
Analyze the clinical vignette for the 32-year-old woman with Sjögren syndrome and kidney stones.
Diagnose Type 1 (distal) Renal Tubular Acidosis.
Sjögren syndrome is a classic autoimmune cause of distal RTA, which leads to calcium phosphate stones due to abnormally alkaline urine and bone buffering of the acidosis.
2
Analyze the diabetic patient's presentation with reduced GFR.
Diagnose Type 4 Renal Tubular Acidosis.
Diabetic nephropathy damages the juxtaglomerular apparatus, reducing renin and aldosterone, leading to hyperkalemia and a mild metabolic acidosis with appropriately acidic urine.
3
Analyze the patient with intractable emesis.
Diagnose volume-responsive metabolic alkalosis.
Gastric acid loss generates alkalosis, and volume depletion maintains it, with the kidney avidly reabsorbing chloride to restore volume (urine Cl < 20 mEq/L).
4
Analyze the smoker with a central lung mass.
Diagnose SIADH.
Ectopic ADH secretion from small cell lung cancer causes water retention, euvolemic hyponatremia, and natriuresis (urine Na > 40 mEq/L).
5
Analyze the bipolar patient on lithium presenting with polyuria.
Diagnose nephrogenic diabetes insipidus.
Lithium impairs ADH action in the collecting duct, leading to large volumes of dilute urine and hypernatremia if water access is insufficient.

Anahtar Kavram

Accurate diagnosis of acid-base and electrolyte disorders requires integrating the patient's clinical history (e.g., autoimmune disease, diabetes, fluid losses, malignancies, medications) with expected serum and urine biochemical patterns.
Tahmini Süre:3m 0s
Soru 4532Soru →

Match each patient's clinical presentation with the primary pathophysiologic mechanism or underlying diagnosis responsible for their electrolyte and acid-base disturbances.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 35-year-old woman with Sjogren syndrome presents with profound hypokalemia, a normal anion gap metabolic acidosis, and recurrent nephrolithiasis. Her urine pH is 6.8.
A 50-year-old man with a monoclonal gammopathy presents with hypokalemia, a normal anion gap metabolic acidosis, and osteomalacia. His urine pH is 5.2.
A 68-year-old man with advanced diabetic nephropathy presents with asymptomatic hyperkalemia and a mild normal anion gap metabolic acidosis. His urine pH is 5.1.
A 22-year-old woman presents with muscle cramps, normal blood pressure, hypokalemia, metabolic alkalosis, and severely decreased urinary calcium excretion.
A 25-year-old woman with poor dentition and enlarged parotid glands presents with hypokalemia, metabolic alkalosis, and a urine chloride level of 8 mEq/L.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches link each distinct clinical presentation to its core pathophysiologic defect. Type 1 RTA matches to impaired distal hydrogen secretion; Type 2 RTA to impaired proximal bicarbonate reabsorption; Type 4 RTA to hypoaldosteronism; Gitelman syndrome to a distal tubule NCCT defect; and surreptitious vomiting to volume depletion with secondary hyperaldosteronism.
Each vignette represents a pathognomonic presentation for a specific nephrology disorder. Matching requires identifying the disease from the clinical clues (e.g., Sjogren for Type 1 RTA, Myeloma for Type 2 RTA, Diabetes for Type 4 RTA, hypocalciuria for Gitelman, and low urine chloride for vomiting) and linking it to its known pathophysiologic mechanism at the level of the nephron.

Adım Adım Çözüm

1
Evaluate the acid-base and potassium status for each clinical vignette.
Patients 1, 2, and 3 have a normal anion gap metabolic acidosis (NAGMA). Patients 4 and 5 have metabolic alkalosis with hypokalemia.
Categorizing into acidosis versus alkalosis immediately narrows the differential diagnosis to Renal Tubular Acidosis (RTA) syndromes versus volume depletion/tubulopathies.
2
Differentiate the NAGMA patients (1, 2, and 3) by their serum potassium levels and urine pH.
Patient 3 has hyperkalemia, which is diagnostic of Type 4 RTA. Patients 1 and 2 have hypokalemia. Patient 1 has a urine pH > 5.5 (diagnostic of Type 1 RTA), while Patient 2 has a urine pH < 5.5 (diagnostic of Type 2 RTA).
Potassium is the key differentiator for Type 4 RTA. Urine pH distinguishes Type 1 (distal failure to acidify) from Type 2 (intact distal acidification once threshold is reached).
3
Differentiate the hypokalemic metabolic alkalosis patients (4 and 5) by their urine chloride levels and physical exam findings.
Patient 5 has a low urine chloride and physical signs of bulimia (vomiting). Patient 4 has hypocalciuria and normal blood pressure without vomiting signs, pointing to Gitelman syndrome.
Urine chloride distinguishes volume-depleted states such as vomiting (< 20 mEq/L) from renal potassium wasting syndromes like Gitelman or Bartter syndrome (> 20 mEq/L).

Anahtar Kavram

Differentiation of complex acid-base and electrolyte disorders requires integrating serum potassium, urine pH, urine chloride, and specific clinical features to identify the precise tubular or systemic defect.
Tahmini Süre:2m 0s
Soru 4533Soru →

Match each clinical presentation and coagulation profile with the most likely underlying hematologic diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 22-year-old woman with a history of heavy menses presents with recurrent epistaxis. Labs show normal PT, prolonged aPTT, normal platelet count, and prolonged bleeding time.
A 14-year-old boy develops severe knee hemarthrosis after a minor fall. Labs show normal PT, prolonged aPTT that corrects with a mixing study, and normal platelet count.
A 68-year-old man in the intensive care unit with gram-negative sepsis begins oozing blood from his intravenous catheter sites. Labs show prolonged PT, prolonged aPTT, thrombocytopenia, and elevated D-dimer.
A 75-year-old man on chronic oral therapy for atrial fibrillation presents with hematuria. Labs show a significantly prolonged PT, normal aPTT, and normal platelet count.
A 28-year-old woman with a history of recurrent spontaneous abortions presents with a deep vein thrombosis. Labs show normal PT and a prolonged aPTT that fails to correct with a mixing study.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Presentation 1 matches von Willebrand disease, 2 matches Hemophilia A, 3 matches DIC, 4 matches Vitamin K antagonist effect, and 5 matches Antiphospholipid syndrome.
Correctly identifying hematologic disorders requires integrating clinical signs (mucosal vs. joint bleeding, thrombosis vs. hemorrhage) with specific laboratory patterns. von Willebrand disease alters bleeding time and mucosal hemostasis. Hemophilia A causes isolated intrinsic pathway defects (prolonged aPTT) with deep joint bleeding. DIC globally consumes both platelets and factors. Vitamin K antagonists primarily affect the extrinsic pathway (isolated prolonged PT initially). Antiphospholipid syndrome presents with paradoxical thrombosis and an artifactual, non-correcting prolonged aPTT.

Adım Adım Çözüm

1
Analyze presentation 1 focusing on mucosal bleeding and prolonged bleeding time.
Identify von Willebrand disease.
Prolonged bleeding time with normal platelets indicates a platelet function defect, typical of vWD which also sometimes prolongs aPTT.
2
Analyze presentation 2 focusing on joint bleeding and prolonged aPTT that corrects.
Identify Hemophilia A.
Correction on a mixing study confirms a factor deficiency (Factor VIII or IX) rather than an inhibitor. Hemarthrosis is classic for hemophilia.
3
Analyze presentation 3 focusing on sepsis and consumptive coagulopathy.
Identify Disseminated intravascular coagulation (DIC).
Simultaneous depletion of platelets and coagulation factors (prolonging both PT and aPTT) with elevated D-dimer is the hallmark of DIC.
4
Analyze presentation 4 focusing on isolated prolonged PT in an anticoagulated patient.
Identify Vitamin K antagonist effect.
Warfarin inhibits vitamin K-dependent factors. Factor VII has the shortest half-life, so PT prolongs before aPTT.
5
Analyze presentation 5 focusing on thrombosis, recurrent miscarriages, and non-correcting aPTT.
Identify Antiphospholipid syndrome.
A prolonged aPTT that fails to correct with normal plasma indicates the presence of an inhibitor (lupus anticoagulant), which is paradoxically prothrombotic.

Anahtar Kavram

Differentiation of bleeding and thrombotic disorders using clinical presentation, platelet count, PT, aPTT, and mixing studies.
Soru 4534Soru →

A 14-day-old male neonate, born prematurely at 28 weeks gestation, is being evaluated in the neonatal intensive care unit for temperature instability and increasing episodes of apnea and bradycardia over the past 12 hours. The nursing staff reports that his abdomen has become visibly distended and firm, and he recently passed a stool containing gross blood. His current enteral feeds via orogastric tube have yielded large, bilious residuals. Laboratory studies show leukocytosis, thrombocytopenia, and a metabolic acidosis. An abdominal radiograph reveals dilated bowel loops with linear radiolucencies in the intestinal walls. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Discontinue enteral feedings, initiate intravenous antibiotics, and place a nasogastric tube

Cevap

The most appropriate next step is to discontinue enteral feedings, initiate broad-spectrum intravenous antibiotics, and place a nasogastric tube for decompression.
The clinical presentation of temperature instability, apnea, feeding intolerance, bilious residuals, bloody stools, and abdominal distension in a premature neonate is highly suspicious for necrotizing enterocolitis (NEC). The abdominal radiograph showing linear radiolucencies in the intestinal wall confirms the presence of pneumatosis intestinalis, the pathognomonic finding of NEC. Once NEC is suspected or confirmed, the immediate next step in management is medical stabilization. This requires prompt cessation of all enteral feeds (bowel rest), gastric decompression with a nasogastric or orogastric tube, aggressive intravenous fluid resuscitation, and initiation of broad-spectrum empiric antibiotics to prevent progression to sepsis and bowel necrosis.

Adım Adım Çözüm

1
Identify the primary clinical syndrome from the patient's presentation.
The premature infant presents with temperature instability, apnea, bradycardia, abdominal distension, bilious residuals, and bloody stools.
These are classic systemic and gastrointestinal signs of necrotizing enterocolitis (NEC) in a premature neonate.
2
Interpret the diagnostic imaging.
The abdominal radiograph shows dilated bowel loops and linear radiolucencies in the intestinal walls (pneumatosis intestinalis).
Pneumatosis intestinalis is the pathognomonic radiographic finding for NEC, confirming the diagnosis.
3
Determine the appropriate initial management for confirmed, uncomplicated NEC.
The standard of care is immediate medical management: bowel rest (NPO), nasogastric decompression, intravenous fluids, and broad-spectrum antibiotics.
Medical stabilization is required to halt disease progression. Surgery is reserved for cases with pneumoperitoneum or clinical deterioration.

Anahtar Kavram

The initial management of necrotizing enterocolitis involves immediate bowel rest (discontinuing enteral feeds), gastric decompression, and broad-spectrum intravenous antibiotics.
Soru 4535Soru →

An 18-year-old male with homozygous sickle cell disease is brought to the emergency department due to a two-day history of progressively worsening chest pain, productive cough, and subjective fevers. Initial vital signs show a temperature of 38.8°C (101.8°F), blood pressure of 118/76 mm Hg, heart rate of 112/min, and respiratory rate of 26/min. Pulse oximetry reveals an oxygen saturation of 87% on room air. Physical examination is notable for scleral icterus and decreased breath sounds with crackles over the right lower lung fields. Laboratory evaluation demonstrates a hemoglobin of 7.2 g/dL, leukocyte count of 16,500/mm³, and reticulocyte count of 12%. A chest radiograph reveals a new consolidation in the right lower lobe.

What is the most appropriate chronological sequence for the management of this patient's condition?

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is to first administer supplemental oxygen and analgesia, followed by empiric intravenous antibiotics, then perform an exchange red blood cell transfusion if clinical deterioration occurs, and finally prescribe daily oral hydroxyurea for long-term prevention after recovery.
The management of acute chest syndrome (ACS) follows a stepwise approach based on acuity. The absolute first priority is stabilization with supplemental oxygen to reverse hypoxia-induced sickling, accompanied by rapid pain control. Once the patient is stabilized, empiric antibiotics (e.g., ceftriaxone and azithromycin) are given because underlying pulmonary infections are the most common trigger for ACS and cannot be reliably distinguished from infarction. If the patient's respiratory status continues to decline or if they present with severe disease (e.g., needing mechanical ventilation), red blood cell exchange transfusion is indicated to rapidly replace HbS with normal hemoglobin. Finally, after the patient has recovered from the acute episode, long-term preventive therapy with hydroxyurea is initiated in the outpatient setting to increase fetal hemoglobin and reduce the frequency of future crises.

Adım Adım Çözüm

1
Analyze the clinical presentation.
The patient has sickle cell disease and presents with fever, chest pain, hypoxia, and a new pulmonary infiltrate, which is diagnostic for acute chest syndrome (ACS).
Establishing the diagnosis of ACS determines the specific treatment pathway.
2
Determine the immediate resuscitative priorities.
Hypoxia and pain promote further red blood cell sickling. Providing supplemental oxygen and parenteral analgesics is the first necessary intervention.
Reversing the acute triggers of sickling prevents the microvascular occlusion from worsening.
3
Identify the underlying trigger and initial medical therapy.
Infection is a leading cause of ACS. Empiric antibiotics covering typical and atypical organisms must be started promptly after initial stabilization.
Pneumonia often triggers or is indistinguishable from ACS, making early antimicrobial therapy the standard of care.
4
Determine the intervention for potential clinical deterioration.
If respiratory status worsens despite initial measures, an exchange transfusion is necessary to acutely lower the hemoglobin S concentration.
Rapid removal of sickled cells restores adequate microvascular perfusion and oxygenation in refractory or severe cases.
5
Establish a long-term preventive plan.
Hydroxyurea therapy is planned for the outpatient setting once the patient recovers from the acute crisis.
Hydroxyurea increases fetal hemoglobin (HbF) and is indicated to prevent future episodes, but it has no role in acute management.

Anahtar Kavram

The management of acute chest syndrome in sickle cell disease begins with immediate supportive care (oxygen, pain control, fluids), followed by empiric antibiotics for potential infectious triggers, exchange transfusion for severe or refractory cases, and finally, long-term prevention with hydroxyurea.
Tahmini Süre:1m 30s
Soru 4536Soru →

An otherwise healthy 42-year-old male is evaluated in the ambulatory care center due to a painful swelling on his right thigh. The lesion has been progressively enlarging over the past three days. He takes no medications and has no significant past medical history. Vital signs demonstrate a temperature of 37.1°C (98.8°F), blood pressure of 122/78 mm Hg, and a heart rate of 74/min. Physical examination of the right anterior thigh reveals a 3-cm, highly tender, fluctuant, erythematous nodule with a central purulent punctum. There is no significant surrounding induration, and no regional lymphadenopathy is appreciated. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Incision and drainage only

Cevap

Incision and drainage only
The correct approach is incision and drainage only. The patient presents with a simple, uncomplicated cutaneous abscess, characterized by a fluctuant, tender nodule with a purulent center. In an otherwise healthy, immunocompetent patient with a single small abscess (typically <5 cm), no systemic signs of infection (such as fever or tachycardia), and minimal surrounding cellulitis, the definitive treatment is mechanical source control. Incision and drainage alone provides excellent cure rates. Systemic antibiotics are not indicated in this scenario.

Adım Adım Çözüm

1
Evaluate the clinical presentation to determine the type and severity of the infection.
The patient has a localized, 3-cm fluctuant mass with a purulent punctum and normal vital signs, indicating a simple, uncomplicated cutaneous abscess.
Categorizing the infection is necessary to determine if both source control and systemic antibiotics are required.
2
Apply current treatment guidelines for an uncomplicated cutaneous abscess.
The standard of care for a single, small abscess in an immunocompetent patient without systemic symptoms is mechanical drainage.
Source control is the most critical intervention for purulent collections.
3
Determine if adjunctive antibiotics are indicated.
Adjunctive antibiotics are unnecessary as the patient lacks high-risk features (e.g., severe extensive surrounding cellulitis, systemic inflammatory response syndrome, immunocompromise).
Prescribing antibiotics when not indicated violates principles of antimicrobial stewardship.

Anahtar Kavram

Management of uncomplicated cutaneous abscesses
Soru 4537Soru →

An 18-year-old female gymnast is brought to the university health clinic by her roommate. She has been vomiting persistently for the past four days. The roommate mentions she has observed similar episodes in the past, though not this severe. Physical examination shows dry mucous membranes, poor skin turgor, and a pulse of 112/min.

Laboratory studies show the following:
- Na+Na^+: 139 mEq/L
- K+K^+: 2.9 mEq/L
- Cl−Cl^-: 94 mEq/L
- HCO3−HCO_3^-: 36 mEq/L

Arterial blood gas analysis on room air reveals:
- pH: 7.52
- pCO2pCO_2: 48 mm Hg
- pO2pO_2: 94 mm Hg

Based on these findings, which of the following best characterizes this patient's acid-base status?

Cevabı ve açıklamayı göster

Cevap: Primary metabolic alkalosis with appropriate respiratory compensation

Cevap

Primary metabolic alkalosis with appropriate respiratory compensation
This patient has a pH of 7.52, indicating an alkalemia. Her significantly elevated HCO3−HCO_3^- of 36 mEq/L establishes that the primary disorder is a metabolic alkalosis, which is classically seen with severe vomiting (due to loss of gastric hydrochloric acid and volume contraction). To determine if a mixed disorder is present, the expected respiratory compensation must be calculated. The lungs compensate for metabolic alkalosis via hypoventilation, which increases the pCO2pCO_2. The formula for expected compensation is: Expected pCO2=40+[0.7×(measured HCO3−−24)]±2pCO_2 = 40 + [0.7 \times (measured\ HCO_3^- - 24)] \pm 2. For this patient, the expected pCO2=40+[0.7×(36−24)]=40+8.4=48.4±2pCO_2 = 40 + [0.7 \times (36 - 24)] = 40 + 8.4 = 48.4 \pm 2 mm Hg (range 46.4 to 50.4 mm Hg). The patient's actual measured pCO2pCO_2 of 48 mm Hg falls perfectly within this range, indicating an appropriate physiological respiratory compensation with no superimposed secondary acid-base disorder.

Adım Adım Çözüm

1
Evaluate the pH to determine the overall acid-base direction.
The pH is 7.52, indicating an alkalemia (pH > 7.45).
The primary disorder must align with the direction of the pH deviation.
2
Examine the pCO2pCO_2 and HCO3−HCO_3^- to identify the primary etiology.
The HCO3−HCO_3^- is significantly elevated at 36 mEq/L, which drives the alkalemia.
Elevated bicarbonate in the setting of alkalemia defines a primary metabolic alkalosis. This is consistent with the patient's history of vomiting, which causes loss of gastric acid (H+H^+) and volume contraction.
3
Calculate the expected respiratory compensation.
Expected pCO2=40+[0.7×(36−24)]=40+[0.7×12]=40+8.4=48.4pCO_2 = 40 + [0.7 \times (36 - 24)] = 40 + [0.7 \times 12] = 40 + 8.4 = 48.4 mm Hg. The normal tolerance range is typically ±2\pm 2 mm Hg (46.4 - 50.4 mm Hg).
The lungs compensate for metabolic alkalosis by hypoventilating to retain CO2CO_2. The formula 0.7×ΔHCO3−0.7 \times \Delta HCO_3^- determines if the respiratory response is adequate.
4
Compare the measured pCO2pCO_2 to the expected range.
The patient's actual pCO2pCO_2 is 48 mm Hg, which is within the expected range.
Because the actual pCO2pCO_2 matches the expected compensation, there is no superimposed secondary acid-base disorder.

Anahtar Kavram

Metabolic alkalosis respiratory compensation calculation
Soru 4538Soru →

A 19-year-old man with type 1 diabetes mellitus is brought to the emergency department due to lethargy, deep and rapid breathing, and a fruity breath odor. Laboratory results show a blood glucose of 580 mg/dL580 \text{ mg/dL}, arterial pH of 7.127.12, serum bicarbonate of 10 mEq/L10 \text{ mEq/L}, and a serum potassium of 5.6 mEq/L5.6 \text{ mEq/L}. He is diagnosed with severe diabetic ketoacidosis (DKA).

Arrange the following management steps in the optimal chronological sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The optimal sequence for managing diabetic ketoacidosis is: initial fluid resuscitation with 0.9%0.9\% normal saline, followed by an intravenous insulin infusion, addition of potassium when levels drop into the normal range, addition of dextrose when glucose reaches 200 mg/dL200 \text{ mg/dL}, and finally transitioning to subcutaneous insulin when the anion gap closes.
Management of DKA requires a strict protocol to safely resolve the metabolic derangements. Initial fluid resuscitation with 0.9%0.9\% normal saline restores intravascular volume. Once potassium is confirmed >3.3 mEq/L>3.3 \text{ mEq/L}, an intravenous regular insulin infusion is started to halt ketogenesis. As insulin therapy shifts potassium intracellularly, potassium must be added to maintenance fluids when serum levels drop <5.2 mEq/L<5.2 \text{ mEq/L}. Because blood glucose drops faster than ketones are cleared, 5%5\% dextrose is added when glucose reaches 200 mg/dL200 \text{ mg/dL} to prevent hypoglycemia while maintaining the insulin drip. Finally, transition to subcutaneous insulin occurs once the anion gap closes and the patient can tolerate oral intake.

Adım Adım Çözüm

1
Administer a rapid intravenous bolus of 0.9%0.9\% normal saline
Restores intravascular volume and tissue perfusion
Severe osmotic diuresis leads to profound volume depletion. Reversing this shock state is the absolute top priority.
2
Initiate a continuous intravenous regular insulin infusion
Halts lipolysis and ketogenesis
Insulin drives glucose into cells and stops ketone production. It can be safely started because the initial potassium is well above the 3.3 mEq/L3.3 \text{ mEq/L} threshold.
3
Add potassium chloride to the intravenous fluids once serum potassium falls below 5.2 mEq/L5.2 \text{ mEq/L}
Prevents severe hypokalemia
Despite total body potassium depletion, initial serum potassium is often high or normal due to acidemia. As insulin therapy drives potassium into cells, levels drop rapidly, requiring proactive supplementation.
4
Add 5%5\% dextrose to the intravenous fluids once serum glucose reaches 200 mg/dL200 \text{ mg/dL}
Prevents hypoglycemia while allowing insulin to continue
Blood glucose levels typically normalize faster than the ketoacidosis resolves. Dextrose must be given so the insulin drip can safely continue to close the anion gap.
5
Transition to a subcutaneous basal-bolus insulin regimen
Establishes long-term glycemic control
This transition is safe only when the acute crisis has resolved (evidenced by a closed anion gap) and the patient is able to eat.

Anahtar Kavram

Diabetic Ketoacidosis (DKA) Stepwise Management
Tahmini Süre:2m 0s
Soru 4539Soru →

A 6262-year-old man with poorly controlled type 2 diabetes mellitus is admitted to the hospital with a non-healing ulcer on the plantar aspect of his right foot. The ulcer is surrounded by 44 cm of erythema and warmth. During physical examination, a sterile metal probe easily reaches the underlying bone. His temperature is 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}), blood pressure is 130/80130/80 mm Hg, and pulse is 9696/min. Laboratory studies show a leukocyte count of 14,500/mm314,500/\text{mm}^3. He is started on empiric intravenous vancomycin and piperacillin-tazobactam. A bone biopsy is performed on the second day of admission. By day 55, his fever has resolved, and the erythema has significantly decreased. The bone biopsy cultures grow only Staphylococcus aureus, which is sensitive to oxacillin, cefazolin, and clindamycin, but resistant to penicillin. No Gram-negative bacilli or anaerobes are isolated. Which of the following is the most appropriate next step in pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Discontinue the current regimen and begin intravenous cefazolin

Cevap

Discontinue the current broad-spectrum regimen and begin intravenous cefazolin to specifically target Methicillin-Susceptible Staphylococcus aureus (MSSA).
The correct answer is to discontinue the broad-spectrum regimen and begin intravenous cefazolin. This patient presented with a diabetic foot infection complicated by osteomyelitis, which appropriately prompted empiric therapy with vancomycin and piperacillin-tazobactam. The gold standard for diagnosing the causative organism in osteomyelitis is a bone biopsy. The culture unequivocally identified Methicillin-Susceptible Staphylococcus aureus (MSSA) as the sole pathogen, with no Gram-negative or anaerobic organisms isolated. According to the core principles of antimicrobial stewardship, therapy must be de-escalated to the most narrow-spectrum, effective agent once culture and susceptibility data are available. Intravenous cefazolin (or an anti-staphylococcal penicillin such as nafcillin) is the treatment of choice for MSSA osteomyelitis because it is highly efficacious, narrow-spectrum, and avoids the selective pressure for multi-drug resistant organisms.

Adım Adım Çözüm

1
Identify the primary diagnosis and clinical scenario.
The patient has a diabetic foot ulcer with underlying osteomyelitis (indicated by a positive probe-to-bone test), initially appropriately treated with empiric broad-spectrum antibiotics.
To establish the baseline clinical state and the original indication for broad-spectrum therapy.
2
Interpret the definitive diagnostic data.
Bone biopsy culture at day 5 shows exclusively Staphylococcus aureus that is sensitive to oxacillin, confirming it is Methicillin-Susceptible S. aureus (MSSA).
Bone biopsy is the gold standard for defining the microbiology of osteomyelitis, superseding the initial assumption of a polymicrobial infection.
3
Apply principles of antimicrobial stewardship.
The empiric broad-spectrum coverage (vancomycin and piperacillin-tazobactam) must be de-escalated to target only MSSA.
To prevent antibiotic resistance, reduce toxicity, and provide the most efficacious targeted therapy for the specific pathogen isolated.
4
Select the optimal definitive pharmacotherapy.
Intravenous cefazolin is chosen.
Cefazolin is a first-generation cephalosporin and the drug of choice for severe MSSA infections, providing narrow-spectrum, highly bactericidal activity.

Anahtar Kavram

Antimicrobial stewardship dictates the de-escalation of empiric broad-spectrum antibiotics to targeted, narrow-spectrum therapy based on definitive culture results; intravenous cefazolin (or an anti-staphylococcal penicillin) is the treatment of choice for MSSA osteomyelitis.
Soru 4540Soru →

A female university student in her early 2020 s is evaluated in the rheumatology clinic for a 66-week history of profound fatigue and stiffness in her proximal interphalangeal joints. She notes that the skin across her cheeks becomes persistently red and painful after brief sun exposure. Over the past 1414 days, she has developed noticeable bilateral ankle swelling. Her blood pressure is 145/92145/92 mmHg. Laboratory evaluation shows a serum creatinine of 1.41.4 mg/dL, and urinalysis demonstrates 3+3+ proteinuria with red blood cell casts. Arrange the following clinical interventions in the standard chronological sequence for the definitive diagnostic workup and targeted management of this patient's underlying condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) ANA screening, 2) Confirmatory anti-dsDNA/complement testing, 3) Percutaneous renal biopsy, 4) Targeted induction immunosuppressive therapy.
The evaluation of suspected Systemic Lupus Erythematosus (SLE) follows a strict sequence beginning with highly sensitive screening (ANA). If this is positive, highly specific markers (anti-dsDNA, anti-Smith) are evaluated to confirm the diagnosis. Because this patient exhibits clear signs of renal involvement (edema, proteinuria, RBC casts, elevated creatinine), a renal biopsy is the absolute critical next step to classify the lupus nephritis. Only after the histologic class is definitively established can the appropriate, targeted induction immunosuppressive therapy be safely initiated.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The combination of inflammatory arthritis, photosensitive malar rash, and new-onset nephropathy (hypertension, edema, proteinuria, RBC casts) is highly suspicious for Systemic Lupus Erythematosus (SLE) with lupus nephritis.
Recognizing the syndrome dictates the necessary systemic workup.
2
Determine the optimal first diagnostic test.
Antinuclear antibody (ANA) assay is ordered first.
ANA is the most sensitive screening test for SLE and is universally the first step in the serologic evaluation of suspected connective tissue diseases.
3
Determine the subsequent confirmatory test.
Anti-dsDNA, anti-Smith, and complement levels (C3, C4) are measured.
Because ANA is sensitive but not specific, these highly specific markers confirm the diagnosis of SLE and establish baseline disease activity.
4
Address the end-organ involvement.
A percutaneous renal biopsy is performed.
Clinical and laboratory evidence of nephritis requires histologic classification (Classes I-VI) because treatment pathways diverge significantly based on the tissue pathology.
5
Determine the final management step.
Targeted induction immunosuppression is initiated.
Aggressive regimens (e.g., cyclophosphamide, mycophenolate) carry significant toxicity and are specifically indicated for proliferative forms of lupus nephritis (Class III and IV) as proven by biopsy.

Anahtar Kavram

Sequential evaluation and management of suspected Systemic Lupus Erythematosus and lupus nephritis
Tahmini Süre:1m 0s
ÖncekiSayfa 227 / 414Sonraki